TAVI

Original Contribution

True First-Line Local-Anesthesia Only Protocol for Transfemoral TAVI

10/30/2015

Kerstin D. Piayda; Sameer Gafoor, MD; Stefan Bertog, MD; Mirko Doss, MD; Laura Vaskelyte, MD; Predrag Matic, MD; Jennifer Franke, MD; Ilona Hofmann, MD; Nina Staiger; Markus Reinartz, MD; Horst Sievert, MD

Kerstin D. Piayda; Sameer Gafoor, MD...

An evaluation of the safety and feasibility of transcatheter aortic valve implantation (TAVI) via femoral access under local anesthesia only (without concomitant sedation) as the initial strategy.

An evaluation of the safety and...

10/30/2015

Journal of Invasive Cardiology

Commentary

Transcatheter Aortic Valve Implantation in Patients of Extreme Age: Age is Just a Number

10/01/2015

Falak Shah, MD and John J. Lopez, MD

Falak Shah, MD and John J. Lopez, MD ...

Commentary on this month's article by Orvin et al. Is there an age at which patients should be considered too high risk for TAVI? Unfortunately, the conventional risk models, the STS score and EuroSCORE, are in essence borrowed tools, and are...

Commentary on this month's...

10/01/2015

Journal of Invasive Cardiology

Original Contribution

Efficacy and Safety of Transcatheter Aortic Valve Implantation in Aortic Stenosis Patients With Extreme Age

07/15/2015

Katia Orvin, MD; Abid Assali, MD; Hana Vaknin-Assa, MD; Amos Levi, MD; Gabi Greenberg, MD; Pablo Codner, MD; Yaron Shapira, MD; Alex Sagie, MD; Ran Kornowski, MD

Katia Orvin, MD; Abid Assali, MD; H...

The in-hospital and long-term outcomes of patients at extreme age with severe symptomatic aortic stenosis who underwent transcatheter aortic valve implantation are investigated. Meticulously selected patients at extreme age benefit from TAVI...

The in-hospital and long-term...

07/15/2015

Journal of Invasive Cardiology

Expansion of the Indication of Transcatheter Aortic Valve Implantation – Feasibility and Outcome in "Off-Label" Patients Compared With "On-Label" Patients

04/29/2015

Christian Frerker, MD¹; Jury Schewel, MD¹; Dimitry Schewel, MD¹; Peter Wohlmuth²; Tobias Schmidt, MD¹; Felix Kreidel, MD¹; Ralf Bader, MD³; Karl-Heinz Kuck, MD¹; Ulrich Sch√§fer, MD¹

Christian Frerker, MD1; Jury Schewel...

This study compares both the feasibility and outcomes of “off-label” transcatheter aortic valve replacement (TAVR) patients (n=156) with a standard “on-label” TAVR population (n=435) at a single institution.

This study compares both the...

04/29/2015

Journal of Invasive Cardiology

Correction of Acquired von Willebrand Syndrome by Transcatheter Aortic Valve Implantation

11/26/2014

Olivier Marggraf, MD¹; Sonja Schneppenheim, MD²; Anne Daubmann³; Ulrich Budde, MD²; Moritz Seiffert, MD¹; Hermann Reichenspurner, MD⁴; Hendrik Treede, MD⁴; Stefan Blankenberg, MD¹; Patrick Diemert, MD¹

Olivier Marggraf, MD1; Sonja Schnepp...

Transcatheter aortic valve implantation (TAVI) is gaining importance, but the influence of this new technique on acquired von Willebrand syndrome has never been examined. We conclude that acquired von Willebrand syndrome due to aortic valve...

Transcatheter aortic valve...

11/26/2014

Journal of Invasive Cardiology